Jonathan E. Kaplan

9.7k total citations · 3 hit papers
88 papers, 6.7k citations indexed

About

Jonathan E. Kaplan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jonathan E. Kaplan has authored 88 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Infectious Diseases, 43 papers in Epidemiology and 15 papers in Virology. Recurrent topics in Jonathan E. Kaplan's work include HIV/AIDS Research and Interventions (37 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers) and HIV/AIDS drug development and treatment (15 papers). Jonathan E. Kaplan is often cited by papers focused on HIV/AIDS Research and Interventions (37 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers) and HIV/AIDS drug development and treatment (15 papers). Jonathan E. Kaplan collaborates with scholars based in United States, Uganda and France. Jonathan E. Kaplan's co-authors include Henry Masur, King K. Holmes, Alice K. Pau, Constance A. Benson, John T. Brooks, Debra L. Hanson, Lawrence B. Schonberger, Toni Frederick, Mark S. Dworkin and Scott D. Holmberg and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Jonathan E. Kaplan

88 papers receiving 6.3k citations

Hit Papers

Guidelines for prevention and trea... 1984 2026 1998 2012 2009 2000 1984 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan E. Kaplan United States 38 4.0k 3.5k 1.3k 691 554 88 6.7k
Sheldon H. Landesman United States 47 3.5k 0.9× 3.1k 0.9× 1.7k 1.3× 656 0.9× 913 1.6× 122 6.4k
Robert S. Holzman United States 41 2.3k 0.6× 2.3k 0.7× 724 0.6× 675 1.0× 412 0.7× 156 6.3k
Koya Ariyoshi Japan 40 2.8k 0.7× 2.4k 0.7× 2.8k 2.2× 1.5k 2.1× 346 0.6× 232 6.6k
Tomàs Pumarola Spain 35 2.2k 0.5× 2.5k 0.7× 1.4k 1.1× 463 0.7× 244 0.4× 293 5.0k
Gerald Friedland United States 38 4.0k 1.0× 3.7k 1.1× 1.1k 0.8× 599 0.9× 358 0.6× 89 6.6k
Marshall J. Glesby United States 45 2.6k 0.6× 1.9k 0.5× 1.6k 1.3× 637 0.9× 2.3k 4.2× 179 6.3k
Edward N. Janoff United States 49 2.9k 0.7× 4.5k 1.3× 1.2k 0.9× 1.5k 2.2× 612 1.1× 146 7.9k
Ida M. Onorato United States 41 4.2k 1.0× 3.7k 1.1× 562 0.4× 730 1.1× 174 0.3× 101 6.4k
Félix Gutiérrez Spain 42 3.7k 0.9× 2.2k 0.6× 2.2k 1.7× 349 0.5× 1.7k 3.0× 281 6.5k
Robert C. Holman United States 63 4.6k 1.1× 4.0k 1.2× 960 0.8× 560 0.8× 433 0.8× 218 11.9k

Countries citing papers authored by Jonathan E. Kaplan

Since Specialization
Citations

This map shows the geographic impact of Jonathan E. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Kaplan more than expected).

Fields of papers citing papers by Jonathan E. Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Kaplan. The network helps show where Jonathan E. Kaplan may publish in the future.

Co-authorship network of co-authors of Jonathan E. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan E. Kaplan. A scholar is included among the top collaborators of Jonathan E. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan E. Kaplan. Jonathan E. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiragga, Agnes, Elizabeth Nalintya, Bożena M Morawski, et al.. (2016). Implementation and Operational Research. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(2). e32–e36. 9 indexed citations
2.
Marston, Barbara J., et al.. (2015). Assessment of the Impact of Cotrimoxazole Prophylaxis on Key Outcomes Among HIV-Infected Adults in Low- and Middle-Income Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(Supplement 3). S257–S269. 13 indexed citations
3.
Kaplan, Jonathan E., Kenneth L. Dominguez, Kebba Jobarteh, & Thomas J. Spira. (2015). Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective. Clinical Infectious Diseases. 60(suppl_3). S196–S199. 17 indexed citations
4.
Suthar, Amitabh B., Marco Vitória, Jason M. Nagata, et al.. (2015). Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. The Lancet HIV. 2(4). e137–e150. 52 indexed citations
5.
Kaplan, Jonathan E., Tiffany E. Hamm, Sara E. Forhan, et al.. (2015). The Impact of HIV Care and Support Interventions on Key Outcomes in Low- and Middle-Income Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(Supplement 3). S253–S256. 18 indexed citations
6.
Denison, Julie A., Olivier Koole, Sharon Tsui, et al.. (2014). Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS. 29(3). 361–371. 68 indexed citations
7.
Yazdanpanah, Yazdan, Elena Losina, Xavier Anglaret, et al.. (2005). Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis. AIDS. 19(12). 1299–1308. 65 indexed citations
8.
Goldie, Sue J., Jonathan E. Kaplan, Elena Losina, et al.. (2002). Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia. Archives of Internal Medicine. 162(8). 921–921. 33 indexed citations
9.
Dworkin, Mark S., et al.. (2001). Prophylaxis with Trimethoprim‐Sulfamethoxazole for Human Immunodeficiency Virus–Infected Patients: Impact on Risk for Infectious Diseases. Clinical Infectious Diseases. 33(3). 393–398. 37 indexed citations
10.
Masur, Henry, King K. Holmes, & Jonathan E. Kaplan. (2000). Introduction to the 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 30(s1). S1–S4. 36 indexed citations
11.
Chapman, Louisa E., Timothy A. Green, Bharat Parekh, et al.. (2000). Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 ×106 cells/l. AIDS. 14(9). 1135–1146. 2 indexed citations
12.
Kaplan, Jonathan E., Debra L. Hanson, Mark S. Dworkin, et al.. (2000). Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 30(s1). S5–S14. 556 indexed citations breakdown →
13.
Kaplan, Jonathan E., Rima Khabbaz, Edward L. Murphy, et al.. (1996). Male-to-Female Transmission of Human T-Cell Lymphotropic Virus Types I and II: Association with Viral Load. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(2). 193–201. 113 indexed citations
14.
Wilfert, Catherine M., Henry Masur, Peter Groß, et al.. (1995). Quality Standard for the Prophylaxis of Pneumocystis carinii Pneumonia in Infants and Children Born to Women Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 21(Supplement_1). S132–S133. 5 indexed citations
15.
Groß, Peter, Jonathan E. Kaplan, John P. Phair, et al.. (1995). Indicators for Assessment of Compliance with Quality Standards for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 21(Supplement_1). S138–S141. 3 indexed citations
16.
Woods, Toni, Judith M. Graber, Ronald C. Hershow, et al.. (1995). Investigation of Proviral Load in Individuals Infected with Human T-Lymphotropic Virus Type II. AIDS Research and Human Retroviruses. 11(10). 1235–1239. 12 indexed citations
17.
Lal, Renu B., Cindy M. Buckner, Rima Khabbaz, et al.. (1993). Isotypic and IgG Subclass Restriction of the Humoral Immune Responses to Human T-Lymphotropic Virus Type-I. Clinical Immunology and Immunopathology. 67(1). 40–49. 20 indexed citations
18.
Kaplan, Jonathan E., Yasuhiro Yamamura, Eddy Ríos‐Olivares, et al.. (1989). Seroprevalence of Human T Lymphotropic Virus Type I in Puerto Rico. American Journal of Tropical Medicine and Hygiene. 40(6). 659–662. 5 indexed citations
19.
Weinberg, Jason B., Richard A. Spiegel, Robert S. Janssen, et al.. (1988). Human T-cell lymphotropic virus I and adult T-cell leukemia: Report of a cluster in North Carolina. The American Journal of Medicine. 85(1). 51–58. 12 indexed citations
20.
Janssen, Robert S., Andrew J. Saykin, Jonathan E. Kaplan, et al.. (1988). Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome. Annals of Neurology. 23(S1). S17–S18. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026